+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Eversight Eye and Vision Research Program

Eversight

Eversight is pleased to invite proposals from investigators from our partner institutions for funding promising research projects concerned with vision problems with a special emphasis on projects utilizing human ocular tissue (cornea, other anterior segment structures, posterior segments, optic nerve) or research related to corneal surgery, corneal disease and innovation in eye banking practices. Projects relying solely on animal models will be considered only when their aims are directly related to investigating corneal diseases, surgery or eye bank practices. Funding is provided as seed money to develop promising ideas for research, collect initial data, pilot projects and/or carry out preliminary laboratory work that could facilitate the submission of full-fledged applications for more extensive support from private or governmental agencies. Eye & Vision Research Grants are intended for faculty only (assistant professor level or above).

Available funds will be allocated to proposals showing the greatest potential for advancing scientific knowledge regarding the causes and treatments of visual disorders or eye bank practices. The number of grants to be awarded is subject to availability of discretionary funds.

Awarded applicants are required to submit a final report to summarize the basic findings from their work the following year, as well as reports of any publications or presentations at professional meetings that are related to the topic of the funded research as they occur. All publications, presentations and posters resulting from this research must acknowledge Eversight for its financial support with the proper disclaimer. Eversight will provide appropriate logo files and information upon request.

Finally, principal investigators of funded projects that result in a successful commercial enterprise will be encouraged to make a financial contribution to Eversight equal to or greater than the amount awarded to them through the Eye & Vision Research Grant Program.

Proposal parameters

No budget will be approved beyond $15,000.
These research grants are intended to support the work of young investigators or new research directions for more established researchers, but are not meant to augment support for research that is already funded.
Funding will be for a period of one (1) year, but in certain cases we can grant no-cost extensions for one (1) additional year.
Applicants who have received funding from Eversight in previous funding cycle are not eligible to apply for funding in this cycle.
Approved budgets for individual projects will not include indirect or overhead charges, training costs and travel expenses.
Applicants will be required to submit a detailed total budget for the proposed project, specifying amounts requested from Eversight and amounts available from all other sources.
Funds cannot be allocated for salary and related expenses.
If funding for acquisition of equipment is requested, its application to the research objective must be clearly explained.
Acknowledgment of Eversight’s support must be included in all publications and presentations of research results together with the appropriate disclaimer. Eversight logo must be included in presentations.
Grant recipients pledge to submit to Eversight notice of publications, presentations and any further funding from other sources.
Researchers must agree to provide Eversight with a publishable summary report or abstract of the methodology and main findings of the project, presented in layman’s terms, at the conclusion of the 12‐month grant cycle. This may be used by Eversight to stimulate public interest in and support for the Eversight Center for Vision and Eye Banking Research.
Failure to meet these requirements could jeopardize future funding in the academic departments or units associated with the investigators.

Review process

All research proposals that meet the eligibility requirements for the Eye & Vision Research Grant Program will be reviewed and evaluated by the Eversight Research Review Committee. The Committee is an independent, volunteer panel of distinguished scientists, ophthalmologists and health services researchers. They will assess the scientific merit and the extent to which each proposal meets with the explicit objectives of the Eye & Vision Research Grant Program. Specific merit criteria include:

The scientific and/or clinical merit of the proposed project and its potential for attracting support from other sources.
The extent to which the proposed research meets the explicit purposes of this research program.
The appropriateness and feasibility of the proposed methodology, including the choice of research design, subject selection, data collection methods and analytic design.
The qualifications of the investigator(s) and relevant experience.
The adequacy of the available facilities to carry out the proposed research.
The justification(s) for the proposed budget.
Appropriate approvals for human or animal use. Application for Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval will be accepted at the time of submission. However, funds will not be disbursed until documentation of IRB or IACUC approval is submitted to Eversight.

After all proposal submissions have been reviewed, the Research Review Committee presents its recommendations in the form of a ranking of meritorious projects to the Eversight Board of Directors. The Board serves the final authority for approving the funding for approved proposals.

AI Based Application Success Predictor

Eversight is a leading global nonprofit eye bank whose core mission is to restore sight and prevent blindness through donation, transplantation, and research—all guided by a vision of a world without blindness.

A Brief History

Founded in 1947 as the Illinois Eye-Bank—the fourth such bank in the U.S.—Eversight’s early establishment laid the groundwork for a network of eye banks across the nation.

Through strategic partnerships and expansions—including affiliations with the Michigan and Cleveland Eye-Banks—it evolved into the Midwest Eye-Banks and Transplantation Center (MEBTC) in 1985.

In 2015, the organization unified under the brand Eversight, further expanding its global reach.

In 2019, it launched the Eversight Center for Vision and Eye Banking Research in Cleveland, focusing on innovations such as retinal tissue research.

Most recently, in 2023, Eversight expanded operations into Arizona through partnerships with the Donor Network of Arizona.

Mission, Vision & Values

Mission: Restore sight and prevent blindness through donation, transplantation, and research.

Vision: A world without blindness.

Core Values:

Service: Compassionate, collaborative, and responsive to partners and communities.

Drive: Embraces continuous improvement, innovation, and learning.

Trust: Transparent, accountable, and respectful stewardship of donated gifts.

What Eversight Does

Program Area	Impact & Activities
Tissue Recovery & Transplantation	Works with over 6,000 donor families annually to provide sight-restoring tissues—over 8,000 transplants per year.
Gift of Sight Program	Charitable support for uninsured or underinsured patients—has consistently covered 100% of eligible transplant requests.
Research & Innovation	Provides post-mortem tissues and micro-grants to researchers. Established dedicated research center in 2019, and awarded High Impact Grants for stem cell procedures.
Global Outreach	Builds eye banking infrastructure and provides training in countries like Pakistan, South Korea, Jordan, and the Palestinian Territories.
Education & Training	Trains hundreds of clinicians annually—including surgeons, fellows, and coordinators.
Cultural Recognition	Earned national workplace excellence awards for employee well-being and leadership culture in 2022.

Recent Highlights

In 2022, Eversight celebrated 75 years of transforming lives, despite facing a global cornea storage media shortage. That year alone, they facilitated 11,676 tissues for transplantation, research, and education, serving 32 countries and training over 550 clinicians.

In 2024, a $10,000 donation from Kearny Bank helped sustain operations in New Jersey. Eversight’s “small but mighty” team continues to support high success rates (around 97%) in corneal transplants.

In Summary

Eversight is not just an eye bank—it’s a comprehensive global organization dedicated to combating corneal blindness through clinical service, research innovation, education, and international cooperation.

Specialties

Ophthalmology

Eligibility Requirements

principal investigators of funded projects that result in a successful commercial enterprise will be encouraged to make a financial contribution to Eversight equal to or greater than the amount awarded to them through the Eye & Vision Research Grant Program

Sponsor Details

Sponsor Institute/Organizations: Eversight

Sponsor Type: Corporate/Non-Profit

Address: 3985 Research Park Drive, Ann Arbor, MI

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity